Health Condition 1: H318- Other specified disorders of choroid
Conditions
Interventions
Intervention1: Intravitreal dexamethasone implant: 0.7 mg biodegradeble intravitreal implant
Control Intervention1: NA: NA
Sponsors
LV Prasad Eye Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1.Newly diagnosed patients with CME secondary to intraocular vascular tumors 2.Participant is willing and able to give informed consent for participation in the study. 3.Male and Female, aged 10 years or above. 4.BCVA 20/32 to 20/400 inclusive 5.Central subfoveal OCT thickness > 300 microns
Exclusion criteria
Exclusion criteria: 1.Any co-existing ocular disease other than intraocular tumor which might cause macular edema. 2.Intraocular surgery within 3 months 3.History of IOP elevation in response to steroid treatment in either eye. 4.History of glaucoma or optic nerve head change consistent with glaucoma damage, and/or glaucomatous visual field loss in the study eye.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.BCVA as per ETDRS chart (distance & near acuity) 2.Central subfoveal thickness on OCT 3.Wide-field fundus photograph 4.B scan to document the tumor dimensions 5. IOP Timepoint: 3 months & 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. BCVA as per ETDRS chart (distance & near acuity) 2. Central subfoveal thickness on OCT 3. Wide-field fundus photograph 4. B scan to document the tumor dimensions 5. IOP Timepoint: 3 months,6 months | — |
Countries
India
Contacts
Public ContactDrVishal Raval
LV Prasad Eye Institute
Outcome results
None listed